ICL has officially signed a definitive agreement to acquire the majority of Lavie Bio’s core team, BDD technology platform, microbial bank and data assets, the majority of their development programs, and its commercial products, as well as Evogene’s MicroBoost AI for AG platform.
This milestone didn’t happen overnight. It’s the result of over two years of close collaboration between ICL and Lavie Bio, developing biostimulant solutions that help row crops withstand abiotic stress.
